Animal & Veterinary
REGULATORY ACTIVITIES - March/April 2000
FDA Veterinarian Newsletter March/April 2000 Volume XV, No II
The following firms/individuals received warning letters for offering animals for slaughter that contained illegal drug residues:
- Dennis H. Eldred, Willet Dairy, LP, Locke, NY
- William W. Lemstra, Cascade Dairy, Tulare, CA
- Joe C. Dias, D and M Dairy, Hanford, CA
- John G. Rorer, Edelweiss Farms, Inc., Freedom, NY
- Gary Watson, Gary Watson Dairy, Stephenville, TX
- Mike Rainwater, Progressive Dairy #1, Bakersfield, CA
- James R. Cooksey, Circleville, OH
These violations involved illegal residues of gentamicin in dairy cows, sulfadimethoxine in dairy cows, penicillin in dairy cows, tilmicosin in a cow, and phenylbutazone in a beef cow.
Warning letters were also sent to the following firms/individuals which had a history of offering animals for sale for human food which were adulterated with drug residues. These warning letters stated that these individuals/firms had offered animals for slaughter that contained illegal drug residues:
- Manuel, Daniel, and Ricardo Faria, Faria Farms, Inc., Tipton, CA
- William P. Vander Poel, Tule River Dairy, Tipton, CA
- Fred Schakel, Fred Schakel Dairy #2, Chino, CA
- Marlin S. Irwin, Quarryville, PA
These violations involved illegal residues of penicillin in a cow, sufadimethoxine in a cow, gentamicin in a cow, gentamicin and neomycin in dairy cows.
A warning letter was sent to Bruce C. Rohde, Chief Executive Officer, ConAgra, Inc., Omaha, NE, for violations from Good Manufacturing Practices (GMPs):
S. Michael Forsythe, D.V.M., Owner, Amanda Animal Hospital, Lancaster, OH, received a warning letter for extra-label use of a drug that resulted in drug residues in edible tissue. This drug residue caused the food animal to be adulterated under the Federal Food, Drug, and Cosmetic Act (the Act.)
A warning letter was sent to Richard J. Denier, President, Universal Marketing Services, Inc., Visalia, CA, for distributing UDDERMINT and HoofTect that are new animal drugs not subject to approved New Animal Drug Applications (NADAs.) As such, these products are adulterated and misbranded drugs under the Act.
Graphic A -- Michael P. Doyle, Ph.D.
Graphic B -- Thomas L. Carson, D.V.M., Ph.D.
Graphic C -- Ballard Graham